Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid

The Journal of Clinical Endocrinology &Metabolism, Volume 101, Issue 9, Page L89-L90, September 2016.


http://ift.tt/2cvbI1b